BioCorRx (BICX) Total Current Liabilities (2010 - 2026)

BioCorRx (BICX) has 17 years of Total Current Liabilities data on file, last reported at $8.5 million in Q1 2026.

• Quarterly Total Current Liabilities fell 36.58% year-over-year to $8.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (down 36.58% YoY) and the FY2025 annual result came in at $8.3 million, up 1.2% from the prior year.
• Total Current Liabilities improved to $8.5 million in Q1 2026 per BICX's latest filing, from $8.3 million in the prior quarter.
• The five-year high for Total Current Liabilities was $14.6 million in Q2 2025, with the low at $3667.0 in Q3 2025.
• Average Total Current Liabilities over 5 years is $7.0 million, with a median of $6.4 million recorded in 2023.
• The widest YoY moves for Total Current Liabilities: up 99.03% in 2025, down 99.96% in 2025.
• BioCorRx's Total Current Liabilities stood at $5.4 million in 2022, then rose by 19.9% to $6.4 million in 2023, then gained by 27.62% to $8.2 million in 2024, then grew by 1.2% to $8.3 million in 2025, then rose by 2.66% to $8.5 million in 2026.
• Business Quant data shows BICX's Total Current Liabilities at $8.5 million in Q1 2026, $8.3 million in Q4 2025, and $3667.0 in Q3 2025.